First U.S. patient enrolled in stem cell transplantation/cardiac bypass study aimed at improving heart failure

By Gale Smith

A 59-year-old Houston man became the first individual in the United States to enroll in a study using stem cell transplantation during cardiac bypass to treat severe heart failure.

Clinician-researchers at the Methodist DeBakey Heart & Vascular Center are investigating whether stem cell infusion, delivered during bypass surgery, will generate new blood vessels and improve heart function more than what is accomplished through bypass surgery alone.

The individual underwent a four-hour procedure Tuesday afternoon but because he is enrolled in a single-blind research study, he will not know if he received his own stem cells until study results are released.

"Unlike previous studies where we injected stem cells only, this study includes during cardiac bypass surgery. The goal is to enhance the bypass surgery by causing the formation of new blood vessels at the site of injection," said Dr. Brian Bruckner, cardiac surgeon and principal investigator on the research study at Methodist.

This video is not supported by your browser at this time.

In this study, individuals randomized to receive stem cells will have their stem cells harvested from their own bone marrow in the operating room while they are under anesthesia. After the bone marrow cells are harvested, Bruckner and Methodist cardiovascular surgeon Dr. Michael Reardon perform the bypass procedure. The cells are simultaneously processed to separate stem cells from bone marrow. After performing the bypass, the surgeons then inject the stem cells into the subject's heart, and the procedure is complete.

The Methodist DeBakey Heart & Vascular Center is one of only three centers in the country to have this study available.

"If this study works, this procedure could prevent future patients from needing a heart transplantation or ventricular assist device, which is a mechanical circulatory device used to partially or completely replace the function of a failing heart," said Dr. Jerry Estep, cardiologist and medical director of the Methodist Heart Transplant program. "To be considered for this trial, individuals must have an existing need for and must have a left ventricular ejection fraction of 40 percent or less. Up to 42 subjects will be enrolled in this randomized study nationwide.

The research team cannot guarantee individual benefits from participating in the study.

The technology that processes the , developed by Harvest Technologies, sorts the cells quickly, enabling the procedure to be intra-operative, rather than having the individual come in days prior to surgery for the aspiration procedure.

Provided by Methodist Hospital System

not rated yet
add to favorites email to friend print save as pdf

Related Stories

Stem cells to be injected into the heart

Aug 26, 2005

The University of Pittsburgh Medical Center will begin a clinical trial to determine the feasibility of injecting a patient's own stem cells into the heart.

Stem cells to repair damaged heart muscle

Jun 22, 2007

In the first trial of its kind in the world, 60 patients who have recently suffered a major heart attack will be injected with selected stem cells from their own bone marrow during routine coronary bypass surgery.

How can you heal a broken heart?

Apr 12, 2010

Some patients with heart muscles seriously affected by coronary heart disease may soon be able to benefit from an innovative treatment. Researchers at the Research Centre of the Centre hospitalier de l'Université de ...

Recommended for you

Study: Removing clot helps limit stroke disability

Dec 17, 2014

For the first time in several decades, a new treatment has been shown to limit the damage from a common type of stroke. Researchers in the Netherlands found that mechanically removing a clot in addition to using a clot-busting ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.